Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Daiichi Sankyo to expand research alliance with MorphoSys
Daiichi Sankyo has been engaged in joint research with MorphoSys on its advanced HuCAL phage display antibody library technologies since March 2006. It exercised its option which included
Daiichi Sankyo has been engaged in joint research with MorphoSys on its advanced HuCAL phage display antibody library technologies since March 2006. It exercised its option which included
The settlement will include payment by Lilly of $15 million plus a term that will ensure that Alaska is treated as favorably as any other state that may
Sagent’s Cefepime for injection will be available in 1g and 2g single dose vials. Sagent will begin marketing and shipping cefepime immediately. The introduction of Cefepime for injection
CE Mark approval gives Evalve the ability to train and educate physicians in Europe on the use of the MitraClip device increasing the number of patients who will
LowTop’s low profile design, coupled with its unique ‘no torque’ locking feature, is said to offer surgeons a user-friendly pedicle screw system complete with poly axial and fixed
The investment was led by Sante Ventures and was joined by previous investors, including Memphis Biomed Ventures, the Southern Appalachian Fund, and the Nashville Capital Network. Protein Discovery
In addition to studying the impact of genetics on warfarin dosing, Harvard-Partners Center for Genetics and Genomics (HPCGG) seeks to examine whether a patient’s metabolomic profile might also
Star technology is a production technology that is particularly useful for the production of recombinant human antibodies and proteins. It has a potentially broad application and is effective
The compound will initially be evaluated in a single and multiple dose escalation study in normal, healthy volunteers for safety, tolerability, exposure and inhibition of mechanism-related biomarkers. ARRY-614,
Each unit consists of one common share plus one-half common share purchase warrant. Each whole common share purchase warrant will enable the holder to purchase one common share